• China has reportedly refused to consider halting fentanyl or precursor exports, despite U.S. pressure.
  • The stance complicates bilateral relations and undermines efforts to curb the opioid crisis.
  • U.S. policymakers may respond with additional tariffs or diplomatic measures.

Diplomatic Standoff Over Fentanyl

China has informed U.S. officials that a halt on fentanyl and precursor chemical exports is "not on the table," according to sources familiar with recent discussions. The position, attributed to comments by Howard Lutnick, signals a hardening stance amid ongoing U.S. demands for stronger Chinese action to disrupt the global opioid supply chain.

This development comes despite China’s August 2024 scheduling of several fentanyl precursors—a move initially seen as progress. U.S. officials had hoped for broader cooperation, given fentanyl’s role in over 70,000 American overdose deaths annually. Instead, the refusal suggests a potential backslide in counternarcotics collaboration as broader U.S.-China relations remain strained.

Economic and Policy Fallout

The White House has already linked trade policy to the fentanyl crisis, imposing tariffs on Chinese chemical imports earlier this year. With China’s latest rebuff, analysts expect further economic measures. "This isn’t just about drugs—it’s about leverage," said one Washington-based policy advisor, speaking anonymously due to the sensitivity of ongoing negotiations. "The administration will likely escalate tariffs or sanctions if China won’t budge."

Meanwhile, the HALT Fentanyl Act, which permanently classifies all fentanyl-related substances as Schedule I drugs, underscores U.S. domestic efforts to combat the crisis. But without Chinese cooperation, enforcement remains a challenge. "Precursors keep flowing, and cartels adapt," noted a DEA official involved in transnational investigations.

What Comes Next?

Short-term, the U.S. could expand its tariff list or press allies to isolate Chinese chemical exporters. Long-term, the deadlock may push Washington toward more aggressive interdiction strategies, though experts caution these alone won’t stem the supply. "Until China sees a compelling reason to act, the status quo will hold," said a former State Department narcotics negotiator. Attempts to reach China’s Ministry of Commerce for comment were unsuccessful.